R2- and R2*-MRI has become an important clinical tool to noninvasively quantify liver iron concentration (LIC) in patients with significant iron overload who may require iron-reducing therapy. However, these highly specialized exams can only be performed on dedicated 1.5T scanners meeting certain technical specifications. Therefore, a priori selection of patients according to their pre-test probabilities of significant iron overload may help correctly match the patients’ clinical needs to the appropriate MRI scanner and exam protocol. This study derives a Bayesian patient selection criterion based on serum ferritin to identify patients who may and may not benefit from dedicated liver iron quantification MRI.
This abstract and the presentation materials are available to members only; a login is required.